Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS’ Blum Assumes New High-Level Duties As ACA Implementation Proceeds

This article was originally published in The Gray Sheet

Executive Summary

CMS Deputy Administrator Jonathan Blum is taking on some of the responsibilities previously handled by CMS Acting Administrator Marilyn Tavenner as the agency faces deadlines in implementing key elements of the health reform law.

You may also be interested in...



Elections Present Next Chance For Device Tax Repeal In Wake Of Supreme Court Decision

With the legal challenges to the Affordable Care Act exhausted by the Supreme Court’s June 28 ruling, politics will now control the fate of the device tax and the rest of the statute.

Berwick Resigns As CMS Administrator; Tavenner To Fill Post

Donald M. Berwick will leave the top spot at CMS Dec. 2, a few weeks before his presidential recess appointment was set to expire, according to Nov. 23 letters to agency staffers from Berwick and HHS Secretary Kathleen Sebelius.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel